Xcel Pharmaceuticals
Focused Innovation for CNS Disorders
General Information
BounceWatch is an independent company data service, not affiliated with Xcel Pharmaceuticals. To contact Xcel Pharmaceuticals, visit xcelpharmaceuticals.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Xcel Pharmaceuticals compare?
A PDF of Xcel Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Xcel Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Xcel Pharmaceuticals
Business keywords: pharmaceuticals, CNS disorders, neurology, epilepsy, migraine, prescription products, sales and marketing, acquisitions, regulatory approval, field sales organization, product candidates, specialty pharmaceuticals
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | $26.00M | 1 |
|
02 Apr 2003 |
| Debt Financing | $62.00M | - |
|
02 Apr 2003 |
| Series B | $22.00M | 1 |
|
05 Jul 2002 |
| Venture Round | $70.00M | 3 |
|
25 Apr 2001 |
Xcel Pharmaceuticals Alternatives & Competitors
View All Alternatives
Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company w...
Developing innovative CNS and pain therapies that significantly address unmet medical needs.
FAQ About Xcel Pharmaceuticals
Source: BounceWatch company record for Xcel Pharmaceuticals, https://bouncewatch.com/company/xcel-pharmaceuticals, updated 20 December 2024. When citing, please name BounceWatch and link this page.
